Cerity Partners LLC Raises Stock Holdings in STERIS plc (NYSE:STE)

Cerity Partners LLC increased its holdings in shares of STERIS plc (NYSE:STE) by 4.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 71,335 shares of the medical equipment provider’s stock after acquiring an additional 2,797 shares during the quarter. Cerity Partners LLC owned approximately 0.07% of STERIS worth $17,302,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Quent Capital LLC boosted its stake in STERIS by 112.7% in the first quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 71 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in STERIS by 3.9% in the first quarter. Advisors Asset Management Inc. now owns 2,681 shares of the medical equipment provider’s stock valued at $603,000 after purchasing an additional 101 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its holdings in STERIS by 11.9% during the first quarter. B. Riley Wealth Advisors Inc. now owns 1,972 shares of the medical equipment provider’s stock valued at $433,000 after purchasing an additional 209 shares during the period. Tidal Investments LLC increased its position in STERIS by 110.9% in the first quarter. Tidal Investments LLC now owns 12,484 shares of the medical equipment provider’s stock worth $2,807,000 after buying an additional 6,565 shares during the last quarter. Finally, Plato Investment Management Ltd raised its stake in shares of STERIS by 3,015.2% in the first quarter. Plato Investment Management Ltd now owns 4,112 shares of the medical equipment provider’s stock valued at $924,000 after buying an additional 3,980 shares during the period. Institutional investors own 94.69% of the company’s stock.

Analysts Set New Price Targets

STE has been the subject of several research reports. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Stephens reiterated an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. KeyCorp lifted their price objective on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research note on Tuesday, September 3rd. Finally, Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $230.00 to $260.00 in a report on Thursday, October 24th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $253.00.

STERIS Stock Up 0.8 %

Shares of NYSE:STE opened at $216.15 on Tuesday. The company has a market cap of $21.34 billion, a price-to-earnings ratio of 48.94 and a beta of 0.85. STERIS plc has a one year low of $195.47 and a one year high of $248.24. The firm has a fifty day moving average price of $227.28 and a two-hundred day moving average price of $228.76. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.12 by $0.02. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company earned $2.03 earnings per share. Analysts anticipate that STERIS plc will post 9.15 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend is Tuesday, November 19th. STERIS’s dividend payout ratio (DPR) is 52.05%.

Insider Activity at STERIS

In other news, CFO Michael J. Tokich sold 23,332 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the transaction, the chief financial officer now owns 42,930 shares of the company’s stock, valued at $10,603,710. This represents a 35.21 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.14% of the stock is currently owned by insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.